The general biotechnology industry offers gurus many opportunities to increase their portfolio returns. Several biotech stocks, including Gilead Sciences Inc. (NASDAQ:GILD) and Celgene Corp. (NASDAQ:CELG), have positive financial outlooks.
Firms in the biotechnology industry manufacture products and modify processes using technological applications involving biological systems. For example, Gilead Sciences, incorporated in Delaware on June 22, 1987, seeks to improve patient care involving several life-threatening diseases, including AIDS, hepatitis B and C and cardiovascular diseases. The research-based biopharmaceutical firm has commercial sales operations both domestically and globally, with market subsidies in several European and Asian countries. Continue Reading »